Chargement en cours...
Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies
INTRODUCTION: Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with reference to myelofibrosis. AIM: To document the morphological...
Enregistré dans:
| Publié dans: | J Clin Diagn Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
JCDR Research and Publications (P) Limited
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449791/ https://ncbi.nlm.nih.gov/pubmed/28571145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25173.9650 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|